Metropolitan Life Insurance CO 908 Devices Inc. Transaction History

Metropolitan Life Insurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Mar 30, 2023	SELL	$13.18 - $26.28 $56,344 - $112,347	-4,275 Reduced 74.8%	1,440 $27,000
Q1 2022 May 12, 2022	SELL	$13.18 - $26.28 $56,344 - $112,347	-4,275 Reduced 74.8%	1,440 $27,000
Q4 2021 Jun 21, 2023	BUY	$23.17 - $38.77 $99,051 - $165,741	4,275 Added 296.88%	5,715 $147,000
Q4 2021 Mar 30, 2023	BUY	$23.17 - $38.77 $42,215 - $70,638	1,822 Added 46.8%	5,715 $147,000
Q4 2021 Feb 15, 2022	BUY	$23.17 - $38.77 $42,215 - $70,638	1,822 Added 46.8%	5,715 $148,000
Q3 2021 Jun 21, 2023	BUY	$29.99 - $39.13 $73,565 - $95,985	2,453 Added 170.35%	3,893 $126,000
Q3 2021 Mar 30, 2023	BUY	$29.99 - $39.13 $35,748 - $46,642	1,192 Added 44.13%	3,893 $126,000
Q3 2021 Nov 15, 2021	BUY	$29.99 - $39.13 $116,751 - $152,333	3,893 New	3,893 $127,000
Q2 2021 Aug 16, 2021	SELL	$36.7 - $55.11 $110 - $165	-3 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$39.94 - $75.0 $50,364 - $94,575	1,261 Added 87.57%	2,701 $131 Million
Q1 2021 Mar 30, 2023	BUY	$39.94 - $75.0 $50,364 - $94,575	1,261 Added 87.57%	2,701 $130,000
Q1 2021 May 14, 2021	BUY	$39.94 - $75.0 $119 - $225	3 New	3 $131,000

18.4M

14.1K

22K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $61.3M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.